Free Trial

Centessa Pharmaceuticals (CNTA) Earnings Date, Estimates & Call Transcripts

Centessa Pharmaceuticals logo
$17.04 -1.15 (-6.32%)
(As of 11/22/2024 ET)

Centessa Pharmaceuticals Latest Earnings Summary

Upcoming
Earnings Date
Mar. 27Estimated
Actual EPS
(Nov. 12)
-$0.37 Beat By $0.05
Consensus EPS
(Nov. 12)
-$0.42

Centessa Pharmaceuticals issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.37, which beat the consensus estimate of -$0.42 by $0.05. With a trailing EPS of -$1.53, Centessa Pharmaceuticals' earnings are expected to grow next year, from ($1.60) to ($1.50) per share.

CNTA Upcoming Earnings

Centessa Pharmaceuticals' next earnings date is estimated for Thursday, March 27, 2025, based off prior year's reporting schedules.

Get Centessa Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Centessa Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CNTA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CNTA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Centessa Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.42-$0.42-$0.42
Q2 20241-$0.41-$0.41-$0.41
Q3 20242-$0.44-$0.42-$0.43
Q4 20242-$0.41-$0.40-$0.41
FY 20246-$1.68-$1.65-$1.67
Q1 20251-$0.35-$0.35-$0.35
Q2 20251-$0.39-$0.39-$0.39
Q3 20251-$0.42-$0.42-$0.42
Q4 20251-$0.39-$0.39-$0.39
FY 20254($1.55)($1.55)($1.55)

Centessa Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/27/2025
(Estimated)
------- 
11/12/2024--$0.42-$0.37+$0.05-$0.37--
8/13/2024--$0.38-$0.40 -$0.02-$0.40--  
5/13/2024Q1 2024-$0.41-$0.38+$0.03-$0.38--  
3/28/2024Q4 2023-$0.44-$0.38+$0.06-$0.38-$6.85M  
11/13/2023Q3 2023-$0.46-$0.40+$0.06-$0.40--  
8/14/2023Q2 2023-$0.43-$0.26+$0.17-$0.26--  
We recommended Nvidia in 2016, now we’re recommending this… (Ad)

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.
5/12/2023Q1 2023-$0.39-$0.53 -$0.14-$0.53--  
3/30/2023Q4 2022-$0.48-$0.45+$0.03-$0.45--  

Centessa Pharmaceuticals Earnings - Frequently Asked Questions

Centessa Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based off last year's report dates. Learn more on CNTA's earnings history.

In the previous quarter, Centessa Pharmaceuticals (NASDAQ:CNTA) reported ($0.37) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.42) by $0.05. Learn more on analysts' earnings estimate vs. CNTA's actual earnings.

Centessa Pharmaceuticals (NASDAQ:CNTA) has a recorded annual revenue of $6.85 million.

Centessa Pharmaceuticals (NASDAQ:CNTA) has a recorded net income of -$151.09 million. CNTA has generated -$1.53 earnings per share over the last four quarters.

Centessa Pharmaceuticals's earnings are expected to grow from ($1.60) per share to ($1.50) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:CNTA) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners